Ransohoff to moderate upcoming Biotech Forum

New biomarkers will play a key role in expanding the applications of personalized medicine, but the development and regulatory hurdles are significant. The Biotech Forum will be lead by a panel of leading thought leaders that will stimulate discussion regarding new applications for biomarkers, key trends in companion diagnostics, best practices for clinical research in the field, and regulatory challenges in the personalized medicine arena.

Event details

When

Apr 11, 2012
from 05:30 PM to 08:00 PM

Where

NC Biotechnology Center

Contact Name

Add event to calendar

Panelists:

  • David Ransohoff, M.D., Professor of Medicine and Epidemiology, UNC School of Medicine (Moderator)
  • Pat Hurban, Ph.D., Vice President of Research & Development, Expression Analysis
  • Kristin Newby, M.D., Professor of Medicine/Cardiology and Director of Biosignatures Advanced Biomarkers Group, Duke University
  • John Ryals, Ph.D., President and Chief Executive Officer, Metabolon
  • Jeff Shuster, Ph.D., General Manager, The Biomarker Factory


Full details and registration information can be found here.

Filed under: